276 filings
8-K
IMNM
Immunome Inc
25 Apr 24
Departure of Directors or Certain Officers
4:01pm
S-3ASR
IMNM
Immunome Inc
3 Apr 24
Automatic shelf registration
4:40pm
S-3ASR
IMNM
Immunome Inc
3 Apr 24
Automatic shelf registration
4:36pm
10-K
2023 FY
IMNM
Immunome Inc
Annual report
28 Mar 24
4:06pm
8-K
IMNM
Immunome Inc
28 Mar 24
Immunome Reports Full-Year 2023 Financial Results and Provides Update on Recently Acquired Assets
4:04pm
8-K
IMNM
Immunome Inc
26 Mar 24
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
8:05am
4
Kinney Horn
21 Feb 24
Immunome / Kinney Horn ownership change
9:10pm
3
Kinney Horn
21 Feb 24
Immunome / Kinney Horn ownership change
9:07pm
8-K
IMNM
Immunome Inc
14 Feb 24
Other Events
4:11pm
424B5
IMNM
Immunome Inc
14 Feb 24
Prospectus supplement for primary offering
4:09pm
424B5
IMNM
Immunome Inc
13 Feb 24
Prospectus supplement for primary offering
4:36pm
8-K
IMNM
Immunome Inc
13 Feb 24
Results of Operations and Financial Condition
4:10pm
S-3ASR
IMNM
Immunome Inc
13 Feb 24
Automatic shelf registration
4:04pm
SC 13G/A
Alpine Global Management, LLC
12 Feb 24
Immunome / Alpine Global Management ownership change
2:10pm
SC 13G
IMNM
Immunome Inc
9 Feb 24
Immunome / FMR ownership change
9:16am
8-K
IMNM
Immunome Inc
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
S-8
IMNM
Immunome Inc
2 Feb 24
Registration of securities for employees
4:04pm
8-K
IMNM
Immunome Inc
31 Jan 24
Departure of Directors or Certain Officers
9:18pm
4
Max Rosett
31 Jan 24
Immunome / Max Rosett ownership change
8:53pm
4
IMNM
Immunome Inc
31 Jan 24
Immunome / Sandra G. Stoneman ownership change
8:50pm